Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00375830 · ClinicalTrials.gov registry record · Phase 2
Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases
A Phase 2 study of Cancer, sponsored by Stanford University.
- Completed
- Registry status
- Phase 2
- Development phase
- 114
- Enrollment target
- 1
- Study location
NCT00375830: Completed Phase 2 study of Cancer, sponsored by Stanford University.
NCT00375830 is a Phase 2 study of Cancer that has completed, run by Stanford University. The registered enrollment target is 114 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00375830, a Phase 2 study of Cancer, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 114 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial studies the use of sodium fluorine-18 (18F-NaF) plus fluorine-18 (18F) fluorodeoxyglucose (FDG) positron emission tomography (PET)/ whole body magnetic resonance imaging (WBMRI) to detect skeletal metastases in patients with stage III-IV breast cancer or stage II-IV prostate cancer.
Primary Outcome
The medical value of 18F-sodium fluoride (NaF) positron emission tomography / computed tomography (PET/CT) vs 99mTc-methylene diphosphonate (MDP) bone scintigraphy was assessed on the basis of the radiation oncologist's medical assessment of image quality and detected extent of disease, for each participant. Per protocol, the data were collected and the outcome is reported for Cohort 1 only. The outcome is reported as the number of participants for whom the medical value of the image was superio
Conditions Studied
Interventions
- PROCEDURE Bone scan
- DRUG 99mTc-methyl diphosphonate
- PROCEDURE Positron Emission Tomography (PET) scan
- DRUG 18F-Fludeoxyglucose (18F-FDG)
- PROCEDURE Computed Tomography (CT) scan
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2006-01 |
| Est. Completion | 2019-03-14 |
| Phase | Phase 2 |
What the finished NCT00375830 record still lists
NCT00375830 is an interventional study that assigns participants to a tested intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 5 interventions - of which Bone scan is the first listed.
NCT00375830 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00375830 about?
NCT00375830 is a clinical study titled "Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases". This clinical trial studies the use of sodium fluorine-18 (18F-NaF) plus fluorine-18 (18F) fluorodeoxyglucose (FDG) positron emission tomography (PET)/ whole body magnetic resonance imaging (WBMRI) to detect skeletal metastases in patients with stage III-IV breast cancer or stage II-IV prostate canc...
What is the current status of trial NCT00375830?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 114 participants. The study started on 2006-01. Estimated completion is 2019-03-14.
What conditions does trial NCT00375830 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT00375830?
The interventions under investigation include: Bone scan (PROCEDURE), 99mTc-methyl diphosphonate (DRUG), Positron Emission Tomography (PET) scan (PROCEDURE), 18F-Fludeoxyglucose (18F-FDG) (DRUG), Computed Tomography (CT) scan (PROCEDURE).
Who is sponsoring clinical trial NCT00375830?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00375830 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00375830's enrollment target sits among peer trials
114 297th of 615 higher than 317 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
RECRUITING · Phase 2
-
CAncer TReatment INformed by the Molecular Tumor Board At Dartmouth
RECRUITING · Phase 2
-
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
RECRUITING · Phase 2
-
Acupuncture for People Experiencing Period Loss Due to Chemotherapy
RECRUITING · Phase 2
-
Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia